fashion -WSS

fashion

author：knowledge 2025-10-02 19:20:02 - browse：31

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： STAT Summit: How researchers deal with rejection

hotspot

WSS

Study on Amgen’s bispecific immunotherapy produces positive data

Roche drug slashes death risk in early

UnitedHealth, Optum discontinue NaviHealth name

Victims of gun violence feel impacts long after bullet wound

10 million people disenrolled from Medicaid over past six months

STAT Summit: Meghan O’Rourke on making chronic illness visible

knowledge

fashion

hotspot

Virginia high school admissions case could be legal follow

Will General Catalyst be the first of many hospital takeovers?

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves potent Eli Lilly obesity drug, Zepbound

Anesthesiologist group: stop taking Ozempic before surgery

FDA approves potent Eli Lilly obesity drug, Zepbound

Virginia high school admissions case could be legal follow

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Medicare details structure of new drug price negotiation program

Study: New antibiotic targets gonorrhea as well as last existing drug

hotspot

UCSF medical school apologizes for unethical prisoner experiments

The new shift in health care is toward less care

Study: New antibiotic targets gonorrhea as well as last existing drug

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Free speech concerns arise in wake of journal editor Eisen's firing

A clever new way to fix Medicaid and graduate medical education

knowledge

hotspot

hotspot

focus